ConductScience.org, home

Gene · 7307

NIH grants1,879

NIH grants whose papers are about the gene, through NIH's grant-paper links.

GrantTitleU2AF1 papersNewest fiscal year
P30AR070549Cincinnati Rheumatic Diseases Resource Center32025
P30CA016056Roswell Park Cancer Center Support Grant32025
P30CA046934University of Colorado Cancer Center Support Grant32025
P30CA125123Baylor College of Medicine Cancer Center - Cancer Center Support Grant32025
P30CA196521The Tisch Cancer Institute - Cancer Center Support Grant32025
R01CA193842Characterizing the MSI2 network in leukemia32025
R01NS099068Binding of Epstein Barr Virus EBNA2 Unifies Multiple Sclerosis Genetic Mechanisms32025
R35CA197449Statistical Methods for Analysis of Massive Genetic and Genomic Data in Cancer Research32025
R35GM118048Signal-Induced Regulation of Alternative RNA Processing32025
T32CA009056Tumor Cell Biology Training Program32025
T32CA009207Investigational Cancer Therapeutics Training Program (ICTTP)32025
T32HL007439Hematology Clinical Research Training Program32025
T32HL116324Training Program in Molecular Hematology32025
U10CA180899Children's Oncology Group Statistics and Data Center32025
U24DK126127Hematology Central Coordinating Center (HCCC) for the NIDDK Hematology Centers Program32025
U24HG009889A comprehensive binding and functional map of human RNA-binding proteins32025
UG1CA189850Northwell Health NCORP32025
UG1CA233180NCTN Lead Academic Participating Site at Dana-Farber/Partners Cancer Care32025
UG1CA233290Lead Academic Participating Site: Memorial Sloan Kettering Cancer Center32025
UL1TR001866Developing, Demonstrating, and Disseminating Innovative Programs to Achieve Translational Success32025

Source NIH's project filesgene-search-2026-11-11-0.2.0

Sources 12

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
  • GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
  • HGNCCC0
  • NCBI GenePublic domain (US government)
  • NIH's project files and grant-paper linksPublic domain
  • Open TargetsCC0 1.0
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
  • GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
  • HGNCCC0: https://www.genenames.org/about/license/
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this list from software.

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/genes/v1/7307/grants?page=4